Austar Lifesciences Limited
AULSF
$0.02
-$0.05-71.43%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.97% | 32.60% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.97% | 32.60% | |||
| Cost of Revenue | 0.97% | 38.11% | |||
| Gross Profit | 0.97% | 11.91% | |||
| SG&A Expenses | 0.97% | 1.63% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -0.97% | 3.49% | |||
| Total Operating Expenses | 0.97% | 33.33% | |||
| Operating Income | 0.96% | 9.92% | |||
| Income Before Tax | 0.96% | -40.58% | |||
| Income Tax Expenses | 0.95% | 29.25% | |||
| Earnings from Continuing Operations | 0.97% | -60.36% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -0.93% | -133.51% | |||
| Net Income | 0.96% | -64.41% | |||
| EBIT | 0.96% | 9.92% | |||
| EBITDA | 0.97% | 8.24% | |||
| EPS Basic | 0.00% | -64.71% | |||
| Normalized Basic EPS | 0.00% | -40.00% | |||
| EPS Diluted | 0.00% | -67.65% | |||
| Normalized Diluted EPS | 0.00% | -40.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||